SEC Filing: Form D
Notice of Exempt Offering of Securities
VYNE TherapeuticsRooted in Innovation
VYNE Therapeutics
Notice of Exempt Offering of Securities
Notice of Exempt Offering of Securities
Other preliminary proxy statements
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Additional definitive proxy soliciting materials and Rule 14(a)(12) material